[Lecture Report] “Policy Discourse on Disease-Modifying Drugs for Dementia and Past Developments” (The 66th Annual Meeting of the Japan Geriatrics Society, Symposium 12: New Trends in Integrated Dementia Care After the Launch of Disease-Modifying Drugs; June 14, 2024; Nagoya City, Aichi Prefecture)
date : 6/24/2024
Tags: Dementia
Mr. Shunichiro Kurita Senior Manager at Health and Global Policy Institute (HGPI) and Ms. Akari Hase, Program Specialist, gave a lecture titled “Policy Discourse on Disease-Modifying Drugs for Dementia and Past Developments” at the 66th Annual Meeting of the Japan Geriatrics Society. The lecture was given during Symposium 12: New Trends in Integrated Dementia Care After the Launch of Disease-Modifying Drugs. During the lecture, Mr. Kurita shared examples demonstrating how policy discourse has changed in Japan and overseas after the recent launch of disease-modifying drugs for dementia. He also shared an analysis on the effects that specialized knowledge in this field has on policy formulation.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: October 1, 2026)
-
2026-09-01
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 6: Japan’s Health Policy through the Lens of Global Security” (October 13, 2026)
-
2026-09-17
[Registration Open] (Webinar) The 145th HGPI Seminar “Toward Better AMR Measures at Elderly Care Facilities—Considering Infectious Disease Control in a Super-Aged Society From a Policy Perspective” (October 27, 2026)



